4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000117
Chief Financial Officer sold 6,606 shares at $28.50 ($188,271)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Girao Tiago Chief Financial Officer | 2026-10-28 | Sale | −6,606 | $28.50 | $188,271 | 234,192 | D |
| Open-market sales · 6,606 sh · avg $28.50 · $188,271 | |||||||
Loading xslF345X06/wk-form4_1793392623.xml…